Express Healthcare

Cardiotrack collaborates with Columbia Asia Hospitals

246

Cardiotrack will capture clinical grade ECG data using cutting-edge technology and ensure data portability through smart devices

Cardiotrack, the pioneer in AI-based diagnostic solutions for cardiac care, has teamed up with Columbia Asia Hospitals in Bangalore to help address the urgent need for timely diagnosis and treatment of cardiac ailments.

As part of this association, Columbia Asia Hospitals will be using Cardiotrack’s hand-held device powered by AI to create an ecosystem that can provide preventive cardiac care to people who may not even be aware that they have heart health problems.

Cardiotrack will capture clinical grade ECG data using cutting-edge technology and ensure data portability through smart devices. That way, there’s no time lapse between diagnosis and treatment – a life-saver in most cases.

Earlier this month, Cardiotrack was successfully used by Columbia Asia Hospital – Whitefield at its recently held heart health camp where close to 100 patients were screened. The results were worrisome and proved that cardiac health in India can be more effective if there is preventive care. In fact, Columbia Asia Hospitals in Hebbal, Yeshwantpur and Mysore have also deployed these devices which will aid patients and doctors in the treatment of cardiac related issues.

Speaking about the company’s association with Columbia Asia Hospitals, Ashim Roy, CEO, Cardiotrack, said, “ By joining hands with Columbia Asia, we hope to make Cardiotrack’s portable and digitised diagnostic solution accessible to a large number of people.”

Reiterating the significance of the association, Pratyush Srivastava, General Manager – Columbia Asia Hospital – Whitefield said, “We at Columbia Asia pride ourselves in providing timely care to our patients. This portable device will definitely help increase the number of corporate and outstation camps we conduct, in turn helping us diagnose cardiac risk at an early stage and provide timely solution.

- Advertisement -

Comments are closed.